A simple prediction rule for all-cause mortality in a cohort eligible for bariatric surgery

JAMA Surgery

Volumn 148, Issue 12, 2013, Pages 1109-1115

  Padwal, Raj S ^a,b   Klarenbach, Scott W ^a   Wang, Xiaoming ^a   Sharma, Arya M ^a,b   Karmali, Shahzeer ^c   Birch, Daniel W ^c   Majumdar, Sumit R ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; SEX RATIO; TREATMENT OUTCOME;

EID: 84890729537     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3953     Document Type: Article

References (39)

1. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19(12):1605-1611.
2. Sjöström L, Narbro K, Sjöström CD, et al; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-752. (Pubitemid 47295641)
3. Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695-704.
4. Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med. 2011;26(10):1183-1194.
5. US Department of Health and Human Services, National Institutes of Health. Gastrointestinal surgery for severe obesity. NIH Consensus Statement. http://consensus.nih.gov/1991/1991gisurgeryobesity084html.htm. Accessed September 18, 2012.
6. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323. (Pubitemid 351159368)
7. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625-633. (Pubitemid 46780646)
8. US Food and Drug Administration. Medical devices: gastric banding. http://fda.gov/MedicalDevices/ProductsandMedicalProcedures/ObesityDevices/ ucm350132.htm. Accessed August 1, 2012.
9. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Surg Obes Relat Dis. 2011;7(4):433-447.
10. Padwal RS, Sharma AM. Treating severe obesity: morbid weights and morbid waits. CMAJ. 2009;181(11):777-778.
11. Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity (Silver Spring). 2010;18(5):865-871.
12. Flum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA. 2007;298(12):1442-1444. (Pubitemid 47481611)
13. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012;379(9833):2300-2311.
14. Livingston EH. Inadequacy of BMI as an indicator for bariatric surgery. JAMA. 2012;307(1):88-89.
15. Welcome to the Clinical Practice Research Datalink. www.cprd.com/intro. asp. Accessed October 2, 2012.
16. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the General Practice Research Database. Pharmacotherapy. 2003;23(5):686-689. (Pubitemid 36539051)
17. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK. Diabet Med. 2006;23(5):516-521.
18. Tannen RL, Weiner MG, Xie D. Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings. BMJ. 2009;338:b81. doi:10.1136/bmj.b81.
19. Lawrenson R, Williams T, Farmer R. Clinical information for research: the use of general practice databases. J Public Health Med. 1999;21(3): 299-304. (Pubitemid 29446069)
20. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4-14.
21. Azoulay L, Schneider-Lindner V, Dell'aniello S, Filion KB, Suissa S. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. 2010;19(4):343-350.
22. Lewis JD, Brensinger C. Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf. 2004;13(7):437-441. (Pubitemid 38996854)
23. Booth HP, Prevost AT, Gulliford MC. Epidemiology of clinical body mass index recording in an obese population in primary care: a cohort study. J Public Health (Oxf). 2013;35(1):67-74.
24. Livingston EH. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg. 2004;188(2):105-110. (Pubitemid 38916726)
25. National Heart, Lung, and Blood Institute, National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the Evidence Report. Bethesda, MD: National Institutes of Health; 1998. NIH publication 98-4083.
26. Office for National Statistics. Mortality statistics: quality and methodology information. 2012. http://ons.gov.uk/ons/index.html. Accessed February 26, 2013.
27. Perk J, De Backer G, Gohlke H, et al; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635-1701.
28. Hensrud DD, Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc. 2006;81(10)(suppl):S5-S10. (Pubitemid 44484960)
29. Bray GA, Pi-Sunyer X, Mulder JE. Health hazards associated with obesity. http://uptodate.com/contents/health-hazards-associated-with-obesity-in-adults. Accessed September 29, 2012.
30. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128-138.
31. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54(1):17-23. (Pubitemid 351182592)
32. Pencina MJ, D'Agostino RBS Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172; 207-212. (Pubitemid 351193639)
33. Robertson HT, de los Campos G, Allison DB. Turning the analysis of obesity-mortality associations upside down: modeling years of life lost through conditional distributions. Obesity (Silver Spring). 2013;21(2):398-404.
34. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):1059-1066. doi:10.1503/cmaj.110387.
35. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211- 2219.
36. Livingston EH, Ko CY. Effect of diabetes and hypertension on obesity-related mortality. Surgery. 2005;137(1):16-25. (Pubitemid 40029371)
37. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-1847. (Pubitemid 28213628)
38. Woloshin S, Schwartz LM, Welch HG. Risk charts: putting cancer in context. J Natl Cancer Inst. 2002;94(11):799-804. (Pubitemid 34705051)
39. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523-1529. (Pubitemid 29504045)